BRIEF published on 08/11/2026 at 13:05, 2 months 12 days ago Aspermont Ltd. Shows Financial Growth Despite Delays Revenue Growth Financial Performance Investment Strategy Aspermont Ltd. Data & Intelligence
PRESS RELEASE published on 08/11/2026 at 13:00, 2 months 12 days ago Original-Research: Aspermont Ltd. (von GBC AG): Buy GBC AG research on Aspermont Ltd. reveals operational transformation and revenue growth, confirming BUY rating with adjusted target price of AUD 5.20 Revenue Growth GBC AG Research Aspermont Ltd. Operational Transformation
BRIEF published on 06/01/2026 at 16:05, 4 months 21 days ago Aspermont Ltd. Shows Positive Momentum in H1 FY2025/26 Revenue Growth Aspermont Ltd. H1 FY2025/26 Results Data & Intelligence Subscription Business
PRESS RELEASE published on 06/01/2026 at 16:00, 4 months 21 days ago Original-Research: Aspermont Ltd. (von GBC AG): BUY Aspermont Ltd. reports solid H1 results with revenue growth and improving cash flow. Strategic focus on Data & Intelligence business. GBC AG recommends BUY with target price of 5.45 AUD Buy Recommendation GBC AG Aspermont Ltd. H1 Results Data & Intelligence
BRIEF published on 03/05/2026 at 10:05, 7 months 18 days ago Aspermont Ltd.: Transition to Data-Driven Intelligence Revenue Growth GBC AG Data Intelligence Aspermont Ltd. Subscription Model
PRESS RELEASE published on 03/05/2026 at 10:00, 7 months 18 days ago Original-Research: Aspermont Ltd. (von GBC AG): Buy Aspermont Ltd. re-initiated coverage by GBC AG with a Buy recommendation and a target price of 5.00 AUD, focusing on growth as a data-driven intelligence platform in the global resources sector Buy Recommendation GBC AG Aspermont Ltd. Re-initiated Coverage Data-driven Intelligence Platform
BRIEF published on 12/18/2024 at 12:06, 1 year 10 months ago Aspermont Ltd. Shows Resilience Amid Market Challenges Aspermont Ltd. Subscription Growth Operational Optimization Revenue Rebound Cash Liquidity
PRESS RELEASE published on 12/18/2024 at 12:01, 1 year 10 months ago Original-Research: Aspermont Ltd. (von GBC AG): Buy GBC AG's Research Report on Aspermont Ltd. highlights resilience in subscriptions and strategic focus, forecasting revenue rebound and profitability in FY2025 GBC AG Research Report Aspermont Ltd. Subscription Services FY2025
BRIEF published on 10/24/2024 at 10:36, 1 year 11 months ago Aspermont Ltd. Sees Revenue Growth in H2 2024 Revenue Growth Digital Media Aspermont Ltd. Subscription Model Cash Reserves
PRESS RELEASE published on 10/24/2024 at 10:31, 1 year 11 months ago Original-Research: Aspermont Ltd. (von GBC AG): Buy Aspermont Ltd.'s H2 2024 results show revenue growth, profitability, and managed cash reserves. Transition to digital model and focus on subscriptions set stage for substantial growth Digital Transformation Revenue Growth Aspermont Ltd. Subscriptions H2 2024 Results
Published on 10/23/2026 at 13:00, 18 minutes ago First Canadian Graphite Inc. Announces Flow-Through Financing
Published on 10/23/2026 at 02:20, 10 hours 58 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 13 hours 48 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 14 hours 48 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 21 hours 18 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/23/2026 at 12:54, 23 minutes ago EQS-Adhoc: Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München: Munich Re reports quarterly net profit of €1.7bn and raises full-year guidance
Published on 10/23/2026 at 12:30, 48 minutes ago Hi3D V1.0 Goes Open Source: The First Production-Validated Open-Source AI 3D Model
Published on 10/23/2026 at 12:25, 53 minutes ago Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
Published on 10/22/2026 at 18:00, 19 hours 18 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 19 hours 18 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 19 hours 18 minutes ago H1 2026: marked improvement in operating results
Published on 10/22/2026 at 17:47, 19 hours 31 minutes ago Aéroports de Paris SA - 2026 9-month revenue
